Combined Administration of Escitalopram Oxalate and Nivolumab Exhibits Synergistic Growth-Inhibitory Effects on Liver Cancer Cells through Inducing Apoptosis.

Chen, Vincent Chin-Hung; Huang, Shao-Lan; Huang, Jing-Yu; Hsu, Tsai-Ching; Tzang, Bor-Show; McIntyre, Roger S

Chen, Vincent Chin-Hung; Huang, Shao-Lan; Huang, Jing-Yu; Hsu, Tsai-Ching; Tzang, Bor-Show; McIntyre, Roger S.

Afiliación

Chen VC; Department of Psychiatry, School of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.
Huang SL; Department of Psychiatry, Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital, Chiayi 61303, Taiwan.
Huang JY; Department of Psychiatry, Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital, Chiayi 61303, Taiwan.
Hsu TC; Department of Psychiatry, Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital, Chiayi 61303, Taiwan.
Tzang BS; Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
McIntyre RS; Immunology Center, Chung Shan Medical University, Taichung 40201, Taiwan.

Int J Mol Sci ; 24(16)2023 Aug 10.

Article en En | MEDLINE | ID: mdl-37628813

Asunto(s)

Escitalopram; Neoplasias Hepáticas; Humanos; Animales; Ratones; Nivolumab/farmacología; Ratones Desnudos; Apoptosis; Neoplasias Hepáticas/tratamiento farmacológico

Palabras clave

escitalopram oxalate (Esc); liver cancer; nivolumab (Niv); synergistic effect

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Escitalopram / Neoplasias Hepáticas Límite: Animals / Humans Idioma: En Revista: Int J Mol Sci Año: 2023 Tipo del documento: Article País de afiliación: Taiwán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google